Les prix des medicaments sur un marche global politiques et enjeux.

The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
Vydáno: (2003)

Profits before people? ethical standards and the marketing of prescription drugs /
Autor: Weber, Leonard J., 1942-
Vydáno: (2006)

The $800 million pill the truth behind the cost of new drugs /
Autor: Goozner, Merrill, 1950-
Vydáno: (2004)

CAPA for the FDA-regulated industry /
Autor: Rodríguez Pérez, José, 1961-
Vydáno: (2010)

Pharmaceutical blending and mixing /
Vydáno: (2015)

The agile approach to adaptive research optimizing efficiency in clinical development /
Autor: Rosenberg, Michael J.
Vydáno: (2010)

Therapeutic targets modulation, inhibition, and activation /
Vydáno: (2012)

Manufacturing of pharmaceutical proteins : from technology to economy /
Autor: Behme, Stefan
Vydáno: (2015)

Innovation in the biopharmaceutical industry
Vydáno: (2007)

Towards drugs of the future key issues in lead finding and lead optimization /
Vydáno: (2008)

The power of pills social, ethical and legal issues in drug development, marketing, and pricing /
Vydáno: (2006)

Negotiating health : intellectual property and access to medicines /
Vydáno: (2006)

Extractables & Leachables : [E & L 2012 conference proceedings] : delivering pharmaceuticals safely : 12-13 December 2012, Vienna, Austria /
Vydáno: (2012)

Extractables & Leachables for Pharmaceutical Products 2011 : [conference proceedings] : Dublin, Ireland, 27-28 September 2011 /
Vydáno: (2011)

E & L USA : Extractables & Leachables : [conference proceedings] : delivering pharmaceuticals safely : 7-9 May 2013, Providence, RI, USA /
Vydáno: (2013)

Forecasting for the pharmaceutical industry models for new product and in-market forecasting and how to use them /
Autor: Cook, Arthur G.
Vydáno: (2006)

Medicines as a service a new commercial model for big pharma in the postblockbuster world /
Autor: Mattke, Soeren
Vydáno: (2012)

Pharmaceutical industry innovation and developments /
Vydáno: (2011)

Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
Vydáno: (2004)

Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
Vydáno: (2007)

Crystallization of organic compounds an industrial perspective /
Autor: Tung, Hsien-Hsin, 1955-
Vydáno: (2009)

Continuous processing in pharmaceutical manufacturing /
Vydáno: (2015)

Drugs : from discovery to approval /
Autor: Ng, Rick
Vydáno: (2015)

Outsourcing clinical development strategies for working with CROs and other partners /
Vydáno: (2006)

Glocal pharma : international brands and the imagination of local masculinity /
Autor: Johnson, Ericka
Vydáno: (2016)

Drug repositioning bringing new life to shelved assets and existing drugs /
Vydáno: (2012)

ADME-enabling technologies for drug design and development
Vydáno: (2012)

The risks of prescription drugs
Vydáno: (2010)

Cracking the code understand and profit from the biostech revolution that will transform our lives and generate fortunes /
Autor: Mellon, Jim
Vydáno: (2012)

Measuring transparency to improve good governance in the public pharmaceutical sector.
Vydáno: (2009)

Measuring transparency to improve good governance in the public pharmaceutical sector.
Vydáno: (2009)

Pharmaceutical reform a guide to improving performance and equity /
Autor: Roberts, Marc J.
Vydáno: (2011)

Coherence for health innovation for new medicines for infectious diseases.
Vydáno: (2009)

Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
Autor: Willig, Sidney H., 1919-
Vydáno: (2000)

Pharmaceutical lifecycle management making the most of each and every brand /
Autor: Ellery, Tony
Vydáno: (2012)

Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
Autor: Osmane, Malik
Vydáno: (2014)